CNTB

Connect Biopharma Holdings
$0.84
−$0.01 (−1.18%)Oct 29, 2026
1.0PoorMoatMint rating

MoatMint rates Connect Biopharma Holdings (CNTB) 1.0 out of 10, a research rating of the company's quality, value, growth, momentum and financial health. Its quality rating is 2.3 out of 10.

Return-94.7%5YRange $0.63 - $15.79
$17.6$11.7$5.9$0.0Nov 21Sep 25Oct 26

Key metrics

The numbers that frame CNTB today
Market cap
$52.58M
Gross margin
100%
EV / Sales
8.9
ROIC
-1,254.7%
Div yield
0%
Debt / equity
0.0
52wk Low
$0.73
52wk High
$3.82

CNTB stock rating

How CNTB scores on quality, value, growth, momentum and financial health
1.0out of 10
Low overallNeutral business, expensive price
Quality2.3
Growth7.7
Momentum0.9
Value0.2
Financial Health1.1

Growth

Revenue and earnings trend for CNTB
RevenueNet income
See the full growth breakdown

Revenue and earnings trends, margins and the multi-year trajectory - free with an account.

Create a free account
Free foreverNo card required
Already a member? Log in

Cash flow & returns

Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture

Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.

Create a free account
Free foreverNo card required
Already a member? Log in

Insider trading

Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade

See who is buying and selling, how much, and when - updated as new filings land.

Create a free account
Free foreverNo card required
Already a member? Log in

Frequently asked questions

Plain-English answers about CNTB
Is Connect Biopharma Holdings a good buy?
No. Connect Biopharma Holdings has poor quality and poor momentum. Both signals point to a weaker setup. Growth looks excellent, which supports the long-term business case, but that is not enough to offset the weak setup. We think Connect Biopharma Holdings is selling at a very high price.
What is the market capitalization of CNTB?
Connect Biopharma Holdings's market capitalization is $52.58M.
What is the 52-week high for CNTB stock?
The 52-week high for Connect Biopharma Holdings is $3.82. The current close of $0.84 is 78.1% below that high.
What is the 52-week low for CNTB stock?
The 52-week low for Connect Biopharma Holdings is $0.73. The current close of $0.84 is 14.1% above that low.
Does CNTB stock pay dividends?
Connect Biopharma Holdings does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for CNTB?
Connect Biopharma Holdings's Debt / Equity ratio is 0.02.